Page last updated: 2024-09-04

moxifloxacin and Pancreatic Neoplasms

moxifloxacin has been researched along with Pancreatic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saini, N; Sultana, S; Varshney, P; Yadav, J; Yadav, V1
Adam, U; Drewelow, B; Förster, S; Hopt, UT; Klar, E; Mundkowski, RG; Wacke, R1

Trials

1 trial(s) available for moxifloxacin and Pancreatic Neoplasms

ArticleYear
Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Pancreas; Pancreatic Neoplasms; Pancreatitis, Acute Necrotizing; Prospective Studies; Quinolines

2006

Other Studies

1 other study(ies) available for moxifloxacin and Pancreatic Neoplasms

ArticleYear
Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation.
    BMC cancer, 2015, Aug-11, Volume: 15

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Cisplatin; Drug Synergism; Fluoroquinolones; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Moxifloxacin; Pancreatic Neoplasms; S Phase

2015